Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the five brokerages that are currently covering the stock, Marketbeat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback